Evolent Health, Inc. (NYSE:EVH) rose considerably to $13.09. On Mar, 13 it was posted by Barchart.com. It has $1.08 billion MC. At $14.01 target, the company’s valuation could be $75.67 million more.
On May, 8 WallStreet anticipated Evolent Health, Inc. (NYSE:EVH)’s earnings release, as reported by RTT. This year’s EPS analyst estimate is anticipated to be $-0.36. That is 1,100.00 % down compareed to $-0.03 EPS for last year. Wall Street predicts 176.92 % negative EPS growth as of May, 8.
Evolent Health, Inc. (NYSE:EVH) Ratings Coverage
In total 8 analysts cover Evolent Health (NYSE:EVH). “Buy” rating has 8, “Sell” are 0, while 0 are “Hold”. 100% are bullish. 14 are the (NYSE:EVH)’s analyst reports since October 4, 2018 according to StockzIntelligence Inc. On Wednesday, February 27 the stock has “Buy” rating by Canaccord Genuity. The stock rating was maintained by Citigroup with “Buy” on Thursday, October 4. In Wednesday, February 27 report Citigroup maintained the stock with “Buy” rating. On Wednesday, February 27 the stock of Evolent Health, Inc. (NYSE:EVH) earned “Buy” rating by Piper Jaffray. On Wednesday, February 27 the company was maintained by Jefferies. On Tuesday, February 26 the rating was maintained by Cantor Fitzgerald with “Buy”. On Monday, March 4 the firm has “Buy” rating by Cantor Fitzgerald given. On Monday, February 25 the firm earned “Buy” rating by Oppenheimer. In Friday, February 22 report Robert W. Baird maintained it with “Buy” rating and $30 target. In Monday, March 4 report KeyBanc Capital Markets maintained the stock with “Overweight” rating.
For more Evolent Health, Inc. (NYSE:EVH) news posted recently go to: Benzinga.com, Bizjournals.com, Investorplace.com, Seekingalpha.com or Prnewswire.com. The titles are as follows: “What The Street Gets Wrong About Evolent Health (NYSE: EVH), Cowen’s ‘Best Small-Mid Cap Idea’ – Benzinga” posted on June 27, 2017, “Passport slashes budget to stave off state takeover – Louisville Business First” on March 01, 2019, “10 Cheap Stocks You Won’t Regret Buying – Investorplace.com” with a publish date: November 21, 2018, “Evolent Health, Inc. (EVH) CEO Frank Williams on Q3 2018 Results – Earnings Call Transcript – Seeking Alpha” and the last “Evolent Health, Inc. Announces Pricing of $150.0 Million of Convertible Senior Notes Due 2025 – PR Newswire” with publication date: October 17, 2018.
Evolent Health, Inc., through its subsidiary, Evolent Health LLC, provides healthcare delivery and payment solutions in the United States.The company has $1.08 billion market cap. It operates as a managed services firm that supports integrated health systems in migration toward value care and population health management.Currently it has negative earnings. The company's services include providing clients with a population management platform, integrated data and analytics capabilities, pharmacy benefit management services, and comprehensive health plan administration services.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.